Vivos Inc.: Volatile OTC Stock with Negative P/E, Seeking Growth
Vivos Inc. (OTC) faces volatility and a negative P/E, but seeks strategic growth and operational efficiency to boost its market position.
2 minutes to read
Vivos Inc
Vivos Inc. on OTC: Navigating Volatility, Negative P/E and Growth Potential
Vivos Inc. on the OTC Bulletin Board: volatile stock, a $35M market cap, negative P/E, and the strategic path to profitability and investor trust.
2 minutes to read
Vivos Inc. Faces Financial Challenges Amid OTC Market Volatility
Vivos Inc., a publicly traded company on the OTC Bulletin Board, is facing financial challenges, including a negative price-to-earnings ratio and significant price fluctuations, which may deter investors but also present opportunities for those will…
2 minutes to read
Vivos Inc. Achieves Milestone with UF Veterinary Certification Amid Market Volatility
Vivos Inc. has achieved a significant milestone by certifying the University of Florida Veterinary Hospital for its IsoPet therapy, but its stock price has experienced notable fluctuations in the past year.
2 minutes to read
Vivos Inc. Reports Record Growth in IsoPet Animal Cancer Treatments Amid Market Volatility
Vivos Inc. has reported record growth in its IsoPet animal cancer treatments during Q1 2025, despite market volatility, positioning the company as a key player in the animal health care industry.
2 minutes to read